Apple Inc. (AAPL): Apple iPhone wait times are broadly in line with last year, while UBS retains a Neutral rating and US$296 target.
UBS Evidence Lab finds largely flat week-on-week iPhone 18 availability and broadly similar year-on-year wait times, with a few exceptions in the US and China. UBS leaves iPhone estimates unchanged but cites margin and supply-chain pressures in its Neutral view.
Summary
UBS Evidence Lab finds largely flat week-on-week iPhone 18 availability and broadly similar year-on-year wait times, with a few exceptions in the US and China. UBS leaves iPhone estimates unchanged but cites margin and supply-chain pressures in its Neutral view.
- US iPhone 18 Pro wait time fell about two days week on week; other model-market combinations were broadly steady.
- Average iPhone 18 Pro Max wait time was about 24 days, versus about 25 days for iPhone 17 Pro Max.
- UBS estimates September-quarter iPhone revenue of US$55.9bn and 55.0m units.
- The US$296 price target is based on about 29x blended CY27/CY28 EPS of US$10.31.
Report Interpretation
Overview
This UBS Evidence Lab update tracks iPhone 18 delivery wait times across more than 30 geographies. UBS finds availability broadly comparable with last year, keeps its iPhone estimates unchanged, and retains a Neutral rating and US$296 price target for Apple.
Core views
UBS Evidence Lab's daily Apple Availability Study tracks iPhone availability across more than 30 geographies. The latest survey showed broadly flat week-on-week wait times. The notable exception was the iPhone 18 Pro in the US, where wait time declined by about two days. UBS therefore views average availability as broadly in line with the comparable point last year, rather than as a material change in underlying demand conditions. The year-on-year comparisons are similarly narrow outside a few market-model combinations. The iPhone 18 Pro showed an average wait of about 17 days, matching both the iPhone 17 Pro and iPhone 16 Pro; the iPhone 18 Pro Max averaged about 24 days, compared with about 25 days for the iPhone 17 Pro Max and about 23 days for the iPhone 16 Pro Max. For the Pro, the US was about two days lower year on year and China about two days higher. For the Pro Max, China was about four days lower year on year. UBS notes that the China Pro Max gap has remained relatively unchanged through the survey, which it views as potentially consistent with consumers waiting for the Duo expected the following month; it believes existing Pro Max users upgrading specifications, particularly in China, would most likely form the initial market for that new form factor. UBS compares the current pattern with the equivalent period last year, when iPhone 17 Pro and Pro Max availability was essentially unchanged week on week except for the Pro in China. Because trends remained similar over the following seven days, UBS expects that if iPhone 18 wait times also remain flat next week, the year-on-year pattern should remain broadly similar, with the China Pro being the only potentially notable change. The availability evidence does not lead UBS to revise its iPhone forecasts. It estimates September-quarter 2026 iPhone revenue of US$55.9bn, up 14.0% year on year and consistent with management's mid-teens growth guidance, on 55.0m units, up 2.8% year on year but below consensus of 57.7m units. For fiscal 2026, UBS estimates iPhone revenue of US$252.4bn, up 20.4% year on year and close to consensus of US$252.2bn, with 261.0m units, up 15.4% year on year and versus consensus of 260.4m units. UBS retains its US$296 price target, derived using a P/E multiple of about 29x blended CY27/CY28 EPS of US$10.31. At that multiple, UBS says Apple would trade roughly two turns below its trailing-12-month average. The valuation reflects what UBS describes as solid iPhone demand, but also increasingly difficult gross-margin headwinds and supply-chain challenges. The report carries a Neutral 12-month rating; its stated forecast price appreciation is -11.1%, with a 0.3% forecast dividend yield and -10.8% forecast stock return.
Analysis framework
UBS uses daily delivery-availability data from its Apple Availability Study to compare iPhone 18 Pro and Pro Max wait times by model and geography, both week on week and against prior iPhone generations at the same point in their launch cycles. It then checks whether the demand signal warrants changes to iPhone revenue and unit forecasts, and values Apple using a P/E multiple on blended CY27/CY28 EPS.
Methodology notes
iPhone availability and delivery wait-time tracking
UBS treats changes in model- and geography-level delivery waits as a timely indicator of the balance between iPhone demand and available supply.
P/E multiple valuation
UBS derives its US$296 target price by applying an approximately 29x P/E multiple to blended CY27/CY28 EPS of US$10.31.
Asset mapping & comparison
Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).
- Apple Inc. (AAPL.O)Primary covered company; iPhone availability trends are used to assess demand and forecast risk.
- Strengths
- UBS cites solid iPhone demand and forecasts FY26 iPhone revenue growth of 20.4% and unit growth of 15.4%.
- Weaknesses
- Increasingly difficult gross-margin headwinds and supply-chain challenges.
- Comparison
- iPhone 18 wait times are broadly in line with iPhone 17 and iPhone 16 at comparable points, apart from selected US and China differences.
- Risks
- Product delays, less innovative offerings, weaker iPhone shipments, China macro weakness, reduced differentiation, regulatory pressure and poor platform management.
Key data
- iPhone 18 Pro average wait time~17 daysVersus ~17 days for both iPhone 17 Pro and iPhone 16 Pro.
- iPhone 18 Pro Max average wait time~24 daysVersus ~25 days for iPhone 17 Pro Max and ~23 days for iPhone 16 Pro Max.
- September 2026-quarter iPhone revenueUS$55.9bn+14.0% YoY; consistent with mid-teens growth guidance.
- September 2026-quarter iPhone units55.0m+2.8% YoY; versus consensus of 57.7m units.
- FY26 iPhone revenue and unitsUS$252.4bn / 261.0m+20.4% / +15.4% YoY; consensus is US$252.2bn / 260.4m.
- Price target valuationUS$296 at ~29x blended CY27/CY28 EPS of US$10.31About two turns below the trailing-12-month average multiple.
Impact & implications
UBS interprets the largely unchanged wait-time pattern as supportive of solid iPhone demand but insufficient to change its forecasts. Its Neutral stance reflects the balance between that demand resilience and increasingly difficult gross-margin and supply-chain conditions.
Risks
- Product delays or less innovative offerings, particularly if iPhone unit shipments decline.
- Macro weakness that dampens product demand, especially in China.
- Reduced product differentiation that enables a successful lower-end smartphone challenge.
- Government regulation as Apple's power increases.
- Poor platform management.
- Gross-margin headwinds and supply-chain challenges.
What to watch
- Whether iPhone 18 wait times remain flat in the following week, which UBS says would preserve broadly similar year-on-year comparisons.
- Whether wait times for the iPhone 18 Pro in China move lower, the principal area UBS identifies as potentially showing a notable change.
- Consumer response to the expected Duo form factor, particularly among China-based Pro Max users upgrading specifications.